Distek, Inc. Releases BIOne 1250 Dual Bioprocess Control Station

April 8, 2021 PR-M04-21-004

North Brunswick, NJ – From the company that has brought you over 45 years of excellence in
laboratory pharmaceutical instruments, Distek, Inc. is proud to introduce the BIOne 1250 Dual
Bioprocess Control Station.


The next evolution of the BIOne Product Line provides the clear solution for upstream laboratories who seek to maximize process throughput when bench space is limited. The BIOne 1250 Dual Bioprocess Control Station maximizes the utility of its compact 18” × 26” footprint, allowing end users simultaneous control of two independent Bioreactor or Fermentation systems from a single central tower. Both Single-Use and Autoclavable Vessels are available for inclusion within your own custom system configuration.


No additional monitors or computers are required for the operation of this stand-alone bioprocessing
solution. Additionally, the User Interface of the controller maintains the same elegance and
intuitiveness that clients have grown to expect from all Distek, Inc. laboratory equipment. Preloaded
Process Recipes, including Cascade and PID settings, ensure that your team will accelerate their
current process development timelines.


For bioprocessing laboratories where efficiency and speed are critical for success, the BIOne 1250
Dual Bioprocess Control Station represents the superior benchtop solution.
To learn more about the new BIOne 1250 Dual Bioprocess Control Station, contact Distek Customer
Service at +1 732 422 7585, email at bione@distekinc.com or visit www.distekinc.com.


ABOUT DISTEK, INC.
Distek engineers highly innovative, technically modern, and user-friendly instruments that provide many innovative features to customers, worldwide. These include water bath and bathless dissolution, media preparation and disposal, in-situ fiber optic UV, bathless tablet disintegration, content uniformity and dissolution autosampling. Distek’s bioprocessing portfolio includes the BIOne single-use bioreactor for cell culture applications as well as the BIOne 1250, an innovative bioreactor control system for both mammalian and microbial models. Distek’s core market includes brand name, generic and biosimilar drug manufacturers, CRO’s, CMO’s, Nutraceuticals, government agencies and universities. Distek holds many instrumentation and accessory patents and has been ISO certified since 2002.

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Distek

Distek engineers highly innovative, technically modern, and user-friendly instruments that provide many innovative features to customers, worldwide. These include water bath and bathless dissolution, media preparation and disposal, in-situ fiber optic UV, bathless tablet disintegration, content uniformity and dissolution autosampling. Distek’s bioprocessing portfolio includes the BIOne single-use bioreactor for cell culture applications as well as the BIOne 1250, an innovative bioreactor control system for both mammalian and microbial models. Distek’s core market includes brand name, generic and biosimilar drug manufacturers, CRO’s, CMO’s, Nutraceuticals, government agencies and universities. Distek holds many instrumentation and accessory patents and has been ISO certified since 2002.

Q: